Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case
The widespread use of bisphosphonates, especially in osteoporosis, has led to a greater number of reports of side effects. We describe for the first time a case of a 75-year-old female patient with a history of indolent sicca syndrome who developed multiple cranial neuropathies after zoledronic acid...
Gespeichert in:
| Veröffentlicht in: | Osteoporosis international 2016-08, Vol.27 (8), p.2627-2629 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2629 |
|---|---|
| container_issue | 8 |
| container_start_page | 2627 |
| container_title | Osteoporosis international |
| container_volume | 27 |
| creator | Deshayes, S. Martin Silva, N. Cogez, J. Baldolli, A. Fedrizzi, S. Bienvenu, B. Aouba, A. |
| description | The widespread use of bisphosphonates, especially in osteoporosis, has led to a greater number of reports of side effects. We describe for the first time a case of a 75-year-old female patient with a history of indolent sicca syndrome who developed multiple cranial neuropathies after zoledronic acid infusion. In this case, the elimination of the main causes of multiple cranial neuropathies, the chronology with zoledronic acid infusion, the absence of secondary complications of the Sjögren’s syndrome, reported cases of similar peripheral nerve injuries with interferon infusions, the spontaneous remission of this multiple cranial neuropathy in parallel with the induced flu-like syndrome, argue for its iatrogenic origin, probably by a great release of inflammatory mediators in this particular background of primary Sjögren’s syndrome. |
| doi_str_mv | 10.1007/s00198-016-3567-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1808673183</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1808673183</sourcerecordid><originalsourceid>FETCH-LOGICAL-c545t-7d43828102a0977d1a4f0602e388773fe64e8b7b398d6e8f615fdda46135357f3</originalsourceid><addsrcrecordid>eNp1kU1rFTEUhoMo9lr9AW4k4MbN2GQyk2TcSLn4BRU3Cu5CbnJym5KbjMkEa_9E_7IZblUouMqBPO9zDrwIPafkNSVEnBVC6CQ7QnnHRi666wdoQwfGun7i40O0IRMT3TTQ7yfoSSlXpGWmSTxGJz2fJBlGsUG3n2tY_BwAm6yj1wFHqDnNern0ULBLIaSfPu7xTQpgc4reYG28xT66WnyKb7DGGYJe2lwu_fwWb4NvVDM50EvNzaKjxasx7WHNW19MLWsYmxQN5Lgu0NjoAk_RI6dDgWd37yn69v7d1-3H7uLLh0_b84vOjMO4dMIOTPaSkl6TSQhL9eAIJz0wKYVgDvgAcid2bJKWg3Scjs5aPXDKRjYKx07Rq6N3zulHhbKoQ7sKQtARUi2KSiK5YFSyhr68h16lmmO7TvWESMKHvh8bRY-UyamUDE7N2R90_qUoUWtb6tiWam2ptS113TIv7sx1dwD7N_Gnngb0R6C0r7iH_G_1_62_ATcAook</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2008064225</pqid></control><display><type>article</type><title>Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case</title><source>MEDLINE</source><source>SpringerNature Journals</source><creator>Deshayes, S. ; Martin Silva, N. ; Cogez, J. ; Baldolli, A. ; Fedrizzi, S. ; Bienvenu, B. ; Aouba, A.</creator><creatorcontrib>Deshayes, S. ; Martin Silva, N. ; Cogez, J. ; Baldolli, A. ; Fedrizzi, S. ; Bienvenu, B. ; Aouba, A.</creatorcontrib><description>The widespread use of bisphosphonates, especially in osteoporosis, has led to a greater number of reports of side effects. We describe for the first time a case of a 75-year-old female patient with a history of indolent sicca syndrome who developed multiple cranial neuropathies after zoledronic acid infusion. In this case, the elimination of the main causes of multiple cranial neuropathies, the chronology with zoledronic acid infusion, the absence of secondary complications of the Sjögren’s syndrome, reported cases of similar peripheral nerve injuries with interferon infusions, the spontaneous remission of this multiple cranial neuropathy in parallel with the induced flu-like syndrome, argue for its iatrogenic origin, probably by a great release of inflammatory mediators in this particular background of primary Sjögren’s syndrome.</description><identifier>ISSN: 0937-941X</identifier><identifier>EISSN: 1433-2965</identifier><identifier>DOI: 10.1007/s00198-016-3567-x</identifier><identifier>PMID: 26980457</identifier><language>eng</language><publisher>London: Springer London</publisher><subject>Acids ; Aged ; Bisphosphonates ; Case Report ; Cranial Nerve Diseases - chemically induced ; Cytokines ; Cytotoxicity ; Diphosphonates - adverse effects ; Endocrinology ; Female ; Fractures ; Hepatitis ; Humans ; Imidazoles - adverse effects ; Inflammation ; Interferon ; Medicine ; Medicine & Public Health ; Orthopedics ; Osteoporosis ; Peripheral neuropathy ; Remission ; Rheumatology ; Sjogren's syndrome ; Sjogren's Syndrome - drug therapy ; Skull ; Tumor necrosis factor-TNF ; Zoledronic acid</subject><ispartof>Osteoporosis international, 2016-08, Vol.27 (8), p.2627-2629</ispartof><rights>International Osteoporosis Foundation and National Osteoporosis Foundation 2016</rights><rights>Osteoporosis International is a copyright of Springer, (2016). All Rights Reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c545t-7d43828102a0977d1a4f0602e388773fe64e8b7b398d6e8f615fdda46135357f3</citedby><cites>FETCH-LOGICAL-c545t-7d43828102a0977d1a4f0602e388773fe64e8b7b398d6e8f615fdda46135357f3</cites><orcidid>0000-0001-8887-3233</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00198-016-3567-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00198-016-3567-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,782,786,27933,27934,41497,42566,51328</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26980457$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Deshayes, S.</creatorcontrib><creatorcontrib>Martin Silva, N.</creatorcontrib><creatorcontrib>Cogez, J.</creatorcontrib><creatorcontrib>Baldolli, A.</creatorcontrib><creatorcontrib>Fedrizzi, S.</creatorcontrib><creatorcontrib>Bienvenu, B.</creatorcontrib><creatorcontrib>Aouba, A.</creatorcontrib><title>Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case</title><title>Osteoporosis international</title><addtitle>Osteoporos Int</addtitle><addtitle>Osteoporos Int</addtitle><description>The widespread use of bisphosphonates, especially in osteoporosis, has led to a greater number of reports of side effects. We describe for the first time a case of a 75-year-old female patient with a history of indolent sicca syndrome who developed multiple cranial neuropathies after zoledronic acid infusion. In this case, the elimination of the main causes of multiple cranial neuropathies, the chronology with zoledronic acid infusion, the absence of secondary complications of the Sjögren’s syndrome, reported cases of similar peripheral nerve injuries with interferon infusions, the spontaneous remission of this multiple cranial neuropathy in parallel with the induced flu-like syndrome, argue for its iatrogenic origin, probably by a great release of inflammatory mediators in this particular background of primary Sjögren’s syndrome.</description><subject>Acids</subject><subject>Aged</subject><subject>Bisphosphonates</subject><subject>Case Report</subject><subject>Cranial Nerve Diseases - chemically induced</subject><subject>Cytokines</subject><subject>Cytotoxicity</subject><subject>Diphosphonates - adverse effects</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Fractures</subject><subject>Hepatitis</subject><subject>Humans</subject><subject>Imidazoles - adverse effects</subject><subject>Inflammation</subject><subject>Interferon</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Orthopedics</subject><subject>Osteoporosis</subject><subject>Peripheral neuropathy</subject><subject>Remission</subject><subject>Rheumatology</subject><subject>Sjogren's syndrome</subject><subject>Sjogren's Syndrome - drug therapy</subject><subject>Skull</subject><subject>Tumor necrosis factor-TNF</subject><subject>Zoledronic acid</subject><issn>0937-941X</issn><issn>1433-2965</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp1kU1rFTEUhoMo9lr9AW4k4MbN2GQyk2TcSLn4BRU3Cu5CbnJym5KbjMkEa_9E_7IZblUouMqBPO9zDrwIPafkNSVEnBVC6CQ7QnnHRi666wdoQwfGun7i40O0IRMT3TTQ7yfoSSlXpGWmSTxGJz2fJBlGsUG3n2tY_BwAm6yj1wFHqDnNern0ULBLIaSfPu7xTQpgc4reYG28xT66WnyKb7DGGYJe2lwu_fwWb4NvVDM50EvNzaKjxasx7WHNW19MLWsYmxQN5Lgu0NjoAk_RI6dDgWd37yn69v7d1-3H7uLLh0_b84vOjMO4dMIOTPaSkl6TSQhL9eAIJz0wKYVgDvgAcid2bJKWg3Scjs5aPXDKRjYKx07Rq6N3zulHhbKoQ7sKQtARUi2KSiK5YFSyhr68h16lmmO7TvWESMKHvh8bRY-UyamUDE7N2R90_qUoUWtb6tiWam2ptS113TIv7sx1dwD7N_Gnngb0R6C0r7iH_G_1_62_ATcAook</recordid><startdate>20160801</startdate><enddate>20160801</enddate><creator>Deshayes, S.</creator><creator>Martin Silva, N.</creator><creator>Cogez, J.</creator><creator>Baldolli, A.</creator><creator>Fedrizzi, S.</creator><creator>Bienvenu, B.</creator><creator>Aouba, A.</creator><general>Springer London</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7TS</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><orcidid>https://orcid.org/0000-0001-8887-3233</orcidid></search><sort><creationdate>20160801</creationdate><title>Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case</title><author>Deshayes, S. ; Martin Silva, N. ; Cogez, J. ; Baldolli, A. ; Fedrizzi, S. ; Bienvenu, B. ; Aouba, A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c545t-7d43828102a0977d1a4f0602e388773fe64e8b7b398d6e8f615fdda46135357f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Acids</topic><topic>Aged</topic><topic>Bisphosphonates</topic><topic>Case Report</topic><topic>Cranial Nerve Diseases - chemically induced</topic><topic>Cytokines</topic><topic>Cytotoxicity</topic><topic>Diphosphonates - adverse effects</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Fractures</topic><topic>Hepatitis</topic><topic>Humans</topic><topic>Imidazoles - adverse effects</topic><topic>Inflammation</topic><topic>Interferon</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Orthopedics</topic><topic>Osteoporosis</topic><topic>Peripheral neuropathy</topic><topic>Remission</topic><topic>Rheumatology</topic><topic>Sjogren's syndrome</topic><topic>Sjogren's Syndrome - drug therapy</topic><topic>Skull</topic><topic>Tumor necrosis factor-TNF</topic><topic>Zoledronic acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Deshayes, S.</creatorcontrib><creatorcontrib>Martin Silva, N.</creatorcontrib><creatorcontrib>Cogez, J.</creatorcontrib><creatorcontrib>Baldolli, A.</creatorcontrib><creatorcontrib>Fedrizzi, S.</creatorcontrib><creatorcontrib>Bienvenu, B.</creatorcontrib><creatorcontrib>Aouba, A.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Physical Education Index</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Osteoporosis international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Deshayes, S.</au><au>Martin Silva, N.</au><au>Cogez, J.</au><au>Baldolli, A.</au><au>Fedrizzi, S.</au><au>Bienvenu, B.</au><au>Aouba, A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case</atitle><jtitle>Osteoporosis international</jtitle><stitle>Osteoporos Int</stitle><addtitle>Osteoporos Int</addtitle><date>2016-08-01</date><risdate>2016</risdate><volume>27</volume><issue>8</issue><spage>2627</spage><epage>2629</epage><pages>2627-2629</pages><issn>0937-941X</issn><eissn>1433-2965</eissn><abstract>The widespread use of bisphosphonates, especially in osteoporosis, has led to a greater number of reports of side effects. We describe for the first time a case of a 75-year-old female patient with a history of indolent sicca syndrome who developed multiple cranial neuropathies after zoledronic acid infusion. In this case, the elimination of the main causes of multiple cranial neuropathies, the chronology with zoledronic acid infusion, the absence of secondary complications of the Sjögren’s syndrome, reported cases of similar peripheral nerve injuries with interferon infusions, the spontaneous remission of this multiple cranial neuropathy in parallel with the induced flu-like syndrome, argue for its iatrogenic origin, probably by a great release of inflammatory mediators in this particular background of primary Sjögren’s syndrome.</abstract><cop>London</cop><pub>Springer London</pub><pmid>26980457</pmid><doi>10.1007/s00198-016-3567-x</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0001-8887-3233</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0937-941X |
| ispartof | Osteoporosis international, 2016-08, Vol.27 (8), p.2627-2629 |
| issn | 0937-941X 1433-2965 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1808673183 |
| source | MEDLINE; SpringerNature Journals |
| subjects | Acids Aged Bisphosphonates Case Report Cranial Nerve Diseases - chemically induced Cytokines Cytotoxicity Diphosphonates - adverse effects Endocrinology Female Fractures Hepatitis Humans Imidazoles - adverse effects Inflammation Interferon Medicine Medicine & Public Health Orthopedics Osteoporosis Peripheral neuropathy Remission Rheumatology Sjogren's syndrome Sjogren's Syndrome - drug therapy Skull Tumor necrosis factor-TNF Zoledronic acid |
| title | Multiple cranial neuropathies following zoledronic acid infusion: a relationship? Clinical features and pathogenic discussion concerning a case |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T11%3A31%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20cranial%20neuropathies%20following%20zoledronic%20acid%20infusion:%20a%20relationship?%20Clinical%20features%20and%20pathogenic%20discussion%20concerning%20a%20case&rft.jtitle=Osteoporosis%20international&rft.au=Deshayes,%20S.&rft.date=2016-08-01&rft.volume=27&rft.issue=8&rft.spage=2627&rft.epage=2629&rft.pages=2627-2629&rft.issn=0937-941X&rft.eissn=1433-2965&rft_id=info:doi/10.1007/s00198-016-3567-x&rft_dat=%3Cproquest_cross%3E1808673183%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2008064225&rft_id=info:pmid/26980457&rfr_iscdi=true |